- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jw Cayman Therapeutics Co Ltd (2126)
Jw Cayman Therapeutics Co Ltd stock price live, this page displays HK 2126 stock exchange data. View the 2126 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jw Cayman Therapeutics Co Ltd real time stock price chart below.
What Is the Jw Cayman Therapeutics Co Ltd Stock Price Today?
The Jw Cayman Therapeutics Co Ltd stock price today is 4.72.
What Is the Stock Symbol for Jw Cayman Therapeutics Co Ltd?
The stock symbol for Jw Cayman Therapeutics Co Ltd is ""2126.""
What Stock Exchange Does Jw Cayman Therapeutics Co Ltd Trade On?
Jw Cayman Therapeutics Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Jw Cayman Therapeutics Co Ltd a Good Stock to Buy?
Determining whether Jw Cayman Therapeutics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2126 quote. (ISIN: KYG5210T1040)
What Is the Jw Cayman Therapeutics Co Ltd Stock Price Today?
The Jw Cayman Therapeutics Co Ltd stock price today is 4.72.
What Is the Stock Symbol for Jw Cayman Therapeutics Co Ltd?
The stock symbol for Jw Cayman Therapeutics Co Ltd is ""2126.""
What Stock Exchange Does Jw Cayman Therapeutics Co Ltd Trade On?
Jw Cayman Therapeutics Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Jw Cayman Therapeutics Co Ltd a Good Stock to Buy?
Determining whether Jw Cayman Therapeutics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2126 quote. (ISIN: KYG5210T1040)
Hong Kong
Currency in HKD
4.72
-0.12(-2.48%)
Closed·
Fair Value
An estimate of a Jw Cayman's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.70
5.04
52 wk Range
1.19
6.44
2126 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
2126 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Jw Cayman's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.705.04
52 wk Range
1.196.44
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2126 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Jw Cayman's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
2.40
Downside
-49.22%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Jw Cayman Therapeutics Co Ltd Company Profile
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China. The company offers cell-based immunotherapies, including CAR-T treatment, a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) immunotherapy for use in the treatment of a range of hematological cancers, as well as systemic lupus erythematosus (SLE), a chronic autoimmune disease. The company’s products pipeline includes JWCAR129, a chimeric antigen receptor (CAR) construct therapy for use in the treatment of multiple myeloma; and JWCAR201, a dual targeting autologous CAR T-cell therapy for use in the treatment of B-cell malignancies and autoimmune diseases. It is also developing JWATM204 and JWATM214 for treating hepatocellular carcinoma (HCC); JWATM203 for the treatment of hepatoblastoma (HB) and hepatocellular carcinoma (HCC) in pediatric patients; JWATM213 for treating HCC; JWTCR001 for the treatment of various solid tumors; and JWCAR031 for the treatment of small cell lung cancer. In addition, the company engages in the drug research and development; medical research and experimental development; import and export handling; and clinical trial and CRO, as well as investment holding activities. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.
Compare 2126 to Peers and Sector
Metrics to compare | 2126 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2126PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | −19.0x | −0.5x | |
PEG Ratio | −1.29 | 0.18 | 0.00 | |
Price/Book | 1.9x | 6.0x | 2.6x | |
Price / LTM Sales | 9.9x | 21.4x | 3.3x | |
Upside (Analyst Target) | −49.2% | −7.8% | 38.9% | |
Fair Value Upside | Unlock | −11.9% | 5.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 2.40
(-49.22% Downside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
-0.85 / -0.72
Revenue / Forecast
71.40M / --
FAQ
What Stock Exchange Does Jw Cayman Trade On?
Jw Cayman is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Jw Cayman?
The stock symbol for Jw Cayman is "2126."
What Is the Jw Cayman Market Cap?
As of today, Jw Cayman market cap is 2.39B.
What Is Jw Cayman's Earnings Per Share (TTM)?
The Jw Cayman EPS (TTM) is -1.49.
From a Technical Analysis Perspective, Is 2126 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Jw Cayman Stock Split?
Jw Cayman has split 0 times.
How Many Employees Does Jw Cayman Have?
Jw Cayman has 292 employees.
What is the current trading status of Jw Cayman (2126)?
As of 30 Aug 2025, Jw Cayman (2126) is trading at a price of 4.72, with a previous close of 4.84. The stock has fluctuated within a day range of 4.70 to 5.04, while its 52-week range spans from 1.19 to 6.44.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.